BiomX Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$41.5M | -$44.5M | -$25.3M | -$27.2M | -$35.5M |
| Operating expenses | — | — | — | $376,000 | — |
| Cash from operations | -$26.4M | -$37.0M | -$21.3M | -$29.1M | -$27.6M |
| Capital expenditure | $2,000 | $30,000 | $50,000 | $112,000 | $3.7M |
| Free cash flow | -$26.4M | -$37.0M | -$21.3M | -$29.2M | -$31.3M |
| Impairments | $11.8M | $3.2M | — | — | — |
| Total assets | $5.8M | $43.2M | $25.0M | $45.5M | $78.0M |
| Total debt | — | — | $10.7M | $14.9M | — |
Shares outstanding 10.1M · Free float 62.5%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.